M. van Houtte

发表

HIV-1 Phenotypic Reverse Transcriptase Inhibitor Drug Resistance Test Interpretation Is Not Dependent on the Subtype of the Virus Backbone

L. Stuyver, W. Stevens, H. de Wolf, 2012, PloS one.

The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype.

V. Calvez, F. Ceccherini‐Silberstein, C. Charpentier, 2011, The Journal of antimicrobial chemotherapy.

A Synthetic HIV-1 Subtype C Backbone Generates Comparable PR and RT Resistance Profiles to a Subtype B Backbone in a Recombinant Virus Assay

D. Nauwelaers, L. Stuyver, K. Van Baelen, 2011, PloS one.

A non-infectious cell-based phenotypic assay for the assessment of HIV-1 susceptibility to protease inhibitors.

Luis Carrasco, Alfredo Castello, B. Clotet, 2012, The Journal of antimicrobial chemotherapy.

Novel Drug Resistance Pattern Associated with the Mutations K70G and M184V in Human Immunodeficiency Virus Type 1 Reverse Transcriptase

J. Ainsworth, S. Malik, T. Pattery, 2007, Antimicrobial Agents and Chemotherapy.

A Rapid Method for Simultaneous Detection of Phenotypic Resistance to Inhibitors of Protease and Reverse Transcriptase in Recombinant Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Antiretroviral Drugs

Brendan Larder, Stuart Bloor, Frank Peeters, 1998, Antimicrobial Agents and Chemotherapy.

Comparative analysis of drug resistance among B and the most prevalent non-B HIV type 1 subtypes (C, F, and CRF02_AG) in Italy.

F. Ceccherini‐Silberstein, P. Narciso, A. Antinori, 2012, AIDS research and human retroviruses.

Natural polymorphism in protease and reverse transcriptase genes and in vitro antiretroviral drug susceptibilities of non-B HIV-1 strains from treatment-naive patients.

L. Stuyver, M. Peeters, E. Delaporte, 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Residual Activity of Two HIV Antiretroviral Regimens Prescribed without Virological Monitoring

L. Bacheler, P. Kaleebu, D. Pillay, 2011, Antimicrobial Agents and Chemotherapy.

A Novel Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutational Pattern Confers Phenotypic Lamivudine Resistance in the Absence of Mutation 184V

K. Hertogs, B. Larder, S. Bloor, 2000, Antimicrobial Agents and Chemotherapy.

Prevalence of HIV-1 drug resistance in antiretroviral-naive patients: a prospective study.

K. Hertogs, W. Verbiest, B. Larder, 2001, AIDS.

Comparison of Drug Resistance Scores for Tipranavir in Protease Inhibitor-Naïve Patients Infected with HIV-1 B and Non-B Subtypes

M. Bickel, H. Doerr, H. Brodt, 2011, Antimicrobial Agents and Chemotherapy.

Broad Phenotypic Cross-Resistance to Elvitegravir in HIV-Infected Patients Failing on Raltegravir-Containing Regimens

V. Soriano, J. Villacian, T. Pattery, 2012, Antimicrobial Agents and Chemotherapy.

A comparison of HIV‐1 drug susceptibility as provided by conventional phenotyping and by a phenotype prediction tool based on viral genotype

Pierre Lecocq, Gaston Picchio, L. Bacheler, 2009, Journal of medical virology.